Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
53.44M
Dividend Yield
0.00%
P/E Ratio
-56.91
EPS
-2.88
Revenue
56.00K
Avg. Volume
6.83K

Recently from Cashu

publisher logo
Cashu

AgeX Therapeutics: Addressing Rising Fall Fatalities Among Aging Population with Innovative Solutions

2 days ago
publisher logo
Cashu

AgeX Therapeutics: The Impact of France's Age Verification Laws on Digital Freedom

12 days ago
publisher logo
Cashu

McDonald's Age Restriction Policy in Franconia Addresses Youth Violence Concerns

about 1 month ago

About

What does SER do?
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.agexinc.com
Stocks
Health Care
ser
AgeX Therapeutics
SER
-0.26 (-4.52%)
5.49
USD
At close at Jun 20, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials